Clinical trial
Celebrex and Metformin for Postoperative Hepatocellular Carcinoma
NCT03184493 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Celebrex and Metformin for Postoperative Hepatocellular Carcinoma
- Lead sponsor
- Guangxi Medical University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 2, 2017
- Completion date
- June 30, 2021
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver cancer